Gledhill, N. (1982). Blood doping and related issues: a brief review. Medicine and Science in Exercise and Sports, 14, 183-189.

"The intent of blood doping is to increase maximal aerobic power by increasing the capacity of blood to carry oxygen. This manipulation gained notoriety in the sports world because of rumors of blood doping by competitors in endurance events. Researchers also have become interested in induced erythrocythemia because its study provides insight into the limiting factor(s) of maximal aerobic power (VO2max). It is concluded in this review that to increase VO2max, it is necessary to elevate significantly the hemoglobin concentration by infusing at least 900 ml of blood. The use of inadequate reinfusion volumes, premature reinfusion of the blood following withdrawal, and storage of the blood by refrigeration rather than by freezing are major reasons for the contradictory findings from earlier studies of blood doping. Changes in blood volume and 2,3-diphosphoglycerate following blood doping are transient and, other than during the first 24 h post infusion, appear to be inconsequential. In addition, this review also examines related issues such as attendant hemodynamic and lactate changes, the need of controls, and ethical considerations in blood doping".

Implication. Blood doping is likely to affect performance if at least two critical factors are involved: 1) the volume infused is sufficiently large (> 900 ml) and 2) the performance occurs soon after infusion (< 24 hours).

Return to Table of Contents for this issue.